ENVOY MEDICAL, INC. (COCH)

0.69 -5.61% (-0.04)

Over 5Y: -92.9%

2026-08-28
5 10
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Operating Cash Flow: -701.4K Q3 '21 — Net Income: 5.6M Q4 '21 — Operating Cash Flow: -885.2K Q4 '21 — Net Income: -4.7M Q1 '22 — Operating Cash Flow: -772.7K Q1 '22 — Net Income: -1.9M Q2 '22 — Operating Cash Flow: -400.2K Q2 '22 — Net Income: -1.2M Q3 '22 — Revenue: 57K Q3 '22 — Operating Cash Flow: -5.3M Q3 '22 — Net Income: -1.3M Q4 '22 — Revenue: 20K Q4 '22 — Operating Cash Flow: -2.4M Q4 '22 — Free Cash Flow: -2.4M Q4 '22 — Net Income: 2.3M Q1 '23 — Revenue: 78K Q1 '23 — Operating Cash Flow: -3M Q1 '23 — Free Cash Flow: -3.1M Q1 '23 — Net Income: -13.3M Q2 '23 — Revenue: 63K Q2 '23 — Operating Cash Flow: -4M Q2 '23 — Free Cash Flow: -4M Q2 '23 — Net Income: -13.3M Q3 '23 — Revenue: 80K Q3 '23 — Operating Cash Flow: 1.1M Q3 '23 — Free Cash Flow: 1M Q3 '23 — Net Income: 1.6M Q4 '23 — Revenue: 95K Q4 '23 — Operating Cash Flow: -11.1M Q4 '23 — Free Cash Flow: -11.2M Q4 '23 — Net Income: -4.9M Q1 '24 — Revenue: 59K Q1 '24 — Operating Cash Flow: -5.6M Q1 '24 — Free Cash Flow: -5.7M Q1 '24 — Net Income: -6.3M Q2 '24 — Revenue: 68K Q2 '24 — Operating Cash Flow: -4.6M Q2 '24 — Net Income: -3.9M Q3 '24 — Revenue: 56K Q3 '24 — Operating Cash Flow: -2.6M Q3 '24 — Free Cash Flow: -3.8M Q3 '24 — Net Income: -6M Q4 '24 — Revenue: 42K Q4 '24 — Operating Cash Flow: -5.1M Q4 '24 — Net Income: -4.6M Q1 '25 — Revenue: 46K Q1 '25 — Operating Cash Flow: -3.7M Q1 '25 — Free Cash Flow: -3.7M Q1 '25 — Net Income: -5M Q2 '25 — Revenue: 78K Q2 '25 — Operating Cash Flow: -4.5M Q2 '25 — Free Cash Flow: -4.5M Q2 '25 — Net Income: -5.7M Q3 '25 — Revenue: 42K Q3 '25 — Operating Cash Flow: -4.3M Q3 '25 — Free Cash Flow: -4.3M Q3 '25 — Net Income: -6.5M Q4 '25 — Revenue: 75K Q4 '25 — Operating Cash Flow: -5.7M Q4 '25 — Free Cash Flow: -5.9M Q4 '25 — Net Income: -6.6M Q1 '26 — Revenue: 39K Q1 '26 — Operating Cash Flow: -6.1M Q1 '26 — Net Income: -4.4M Q2 '26 — Revenue: 51K Q2 '26 — Operating Cash Flow: -5.5M Q2 '26 — Net Income: -6M -12M -8M -4M 0 4M 8M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 388.4%
Accruals -7.8%
Asset turnover 0.0086×
Gross margin -385.5%
ROA -97.7%
ROCE -208.8%
ROE -708.5%
EBITDA margin —
FCF margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

4.6
ND/EBITDA —
Interest cover -715.8×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 1.6×
Cash runway 0.91 yr
F-score 2.2 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -24.7%
Div. growth -25.7%
Sales Q/Q -34.6%
Shares change +23.8%
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.